These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3241653)

  • 61. Opioid modulation of vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Morii N
    Clin Exp Hypertens A; 1988; 10 Suppl 1():361-7. PubMed ID: 3243002
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro.
    Bridges TE; Hillhouse EW; Jones MT
    J Physiol; 1976 Sep; 260(3):647-66. PubMed ID: 988183
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The content of vasopressin and oxytocin in the hypothalamus and neurohypophysis of pinealectomized male rats.
    Juszczak M; Guzek JW
    Acta Physiol Pol; 1983; 34(1):41-6. PubMed ID: 6637529
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insulin and release of neurohypophysial hormones: in vivo and in vitro studies.
    Guzek JW; Lewandowska A; Stempniak B
    Exp Clin Endocrinol; 1988 Sep; 92(1):43-50. PubMed ID: 3068066
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transitory coexistence of oxytocin and vasopressin in the hypothalamo neurohypophysial system of parturient rats.
    Jirikowski GF; Ramalho-Ortigao FJ; Caldwell JD
    Horm Metab Res; 1991 Oct; 23(10):476-80. PubMed ID: 1761278
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allopregnanolone and induction of endogenous opioid inhibition of oxytocin responses to immune stress in pregnant rats.
    Brunton PJ; Bales J; Russell JA
    J Neuroendocrinol; 2012 Apr; 24(4):690-700. PubMed ID: 22340139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enkephalins co-exist with oxytocin and vasopressin in nerve terminals of rat neurohypophysis.
    Martin R; Voigt KH
    Nature; 1981 Feb; 289(5797):502-4. PubMed ID: 7007886
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential modulation of N-type calcium channels by micro-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals.
    Ortiz-Miranda SI; Dayanithi G; Velázquez-Marrero C; Custer EE; Treistman SN; Lemos JR
    J Cell Physiol; 2010 Oct; 225(1):276-88. PubMed ID: 20509142
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Galanin influences on vasopressin and oxytocin release: in vitro studies.
    Izdebska K; Ciosek J
    Neuropeptides; 2010 Aug; 44(4):341-8. PubMed ID: 20466422
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Changes in oxytocin and vasopressin content in posterior pituitary and hypothalamus following pantethine treatment.
    Ong GL; Miaskowski C; Haldar J
    Life Sci; 1990; 47(6):503-6. PubMed ID: 2402177
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activation of kappa-opioid receptors inhibits depolarisation-evoked exocytosis but not the rise in intracellular Ca2+ in secretory nerve terminals of the neurohypophysis.
    Kato M; Chapman C; Bicknell RJ
    Brain Res; 1992 Mar; 574(1-2):138-46. PubMed ID: 1353398
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Thyrotropin-releasing hormone (TRH) and vasopressin and oxytocin release: in vitro as well as in vivo studies.
    Ciosek J; Guzek JW
    Exp Clin Endocrinol; 1992; 100(3):152-9. PubMed ID: 1305067
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of Q-type Ca2+ channels in vasopressin secretion from neurohypophysial terminals of the rat.
    Wang G; Dayanithi G; Kim S; Hom D; Nadasdi L; Kristipati R; Ramachandran J; Stuenkel EL; Nordmann JJ; Newcomb R; Lemos JR
    J Physiol; 1997 Jul; 502 ( Pt 2)(Pt 2):351-63. PubMed ID: 9263915
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of naloxone on vasopressin secretion in conscious rats: evidence for inhibitory role of endogenous opioid peptides in vasopressin secretion.
    Yamada T; Nakao K; Itoh H; Shirakami G; Sugawara A; Saito Y; Mukoyama M; Arai H; Hosoda K; Shiono S
    Endocrinology; 1989 Aug; 125(2):785-90. PubMed ID: 2546748
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland.
    Larsen PJ; Jukes KE; Chowdrey HS; Lightman SL; Jessop DS
    Endocrinology; 1994 Apr; 134(4):1635-9. PubMed ID: 8137725
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of response in the release of oxytocin and vasopressin from isolated neurohypophyses to dopamine, met-enkephalin and leu-enkephalin.
    Pitzel L; König A
    Exp Brain Res; 1984; 56(2):221-6. PubMed ID: 6090193
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The vasopressor and oxytocic activities of the hypothalamus and neurohypophysis influenced by stimulated alpha-adrenergic transmission during dehydration and subsequent rehydration in the white rat.
    Ciosek J; Guzek JW; Morawska J
    Acta Physiol Pol; 1983; 34(3):321-31. PubMed ID: 6326469
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurosteroid regulation of oxytocin and vasopressin release from the rat supraoptic nucleus.
    Widmer H; Ludwig M; Bancel F; Leng G; Dayanithi G
    J Physiol; 2003 Apr; 548(Pt 1):233-44. PubMed ID: 12588901
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The influence of desmethylimipramine on the hypothalamic and neurohypophysial vasopressin content in pinealectomized male rats.
    Juszczak M; Guzek JW
    Exp Clin Endocrinol; 1987 Aug; 90(1):26-36. PubMed ID: 3666058
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proceedings: The neurohypophysial content of vasopressin, oxytocin and neurophysins A, B and C in rats injected with vasopressin tannate.
    Bakker HR; Dyball RE; Jones CW
    J Endocrinol; 1975 Jun; 65(3):60P. PubMed ID: 1151259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.